Tumour markers for ovarian cancer
Author:
- Gordon J.S. RustinGRGordon J.S. Rustin
- 1 January 1992
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer
- Vol. 28 (1) , 2-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Savings obtained by CA-125 measurements during therapy for ovarian carcinomaEuropean Journal of Cancer, 1992
- A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancerBJOG: An International Journal of Obstetrics & Gynaecology, 1990
- The role of CA 125 in the early diagnosis of progressive disease in ovarian cancerAnnals of Oncology, 1990
- Urinary gonadotropin fragment, a new tumor markerGynecologic Oncology, 1990
- Inhibin as a Marker for Granulosa-Cell TumorsNew England Journal of Medicine, 1989
- The CA 125 tumour-associated antigen: a review of the literatureHuman Reproduction, 1989
- Ovarian cancer: The prognostic value of the serum half-life of CA125 during induction chemotherapyGynecologic Oncology, 1988
- Evaluation of serum CA 125 levels in the monitoring of ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1987
- CA125 as a serum marker for poor prognosis in ovarian malignanciesGynecologic Oncology, 1987
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983